Literature DB >> 9416894

Late left ventricular function after surgery for children with chronic symptomatic mitral regurgitation.

U S Krishnan1, W M Gersony, E Berman-Rosenzweig, H D Apfel.   

Abstract

BACKGROUND: The use of quantitative echocardiography has been emphasized in optimizing timing of surgery in adult patients with mitral regurgitation to avoid irreversible left ventricular dysfunction. In contrast, surgery for infants and children is often delayed until the appearance of severe symptoms because of the patient's size and anticoagulation requirements and the possible need for early reoperation. The purpose of this study was to determine long-term ventricular function after mitral valve surgery in symptomatic children and to analyze risk factors for adverse outcome. METHODS AND
RESULTS: Thirty-three patients (0.5 to 19 years old) operated on for mitral regurgitation as a single hemodynamically significant lesion were studied. All but 3 had medically refractory symptoms. One patient died during surgery, and 32 were followed for 0.3 to 17.1 years (mean, 4.5 years). The mean preoperative left ventricular shortening fraction was 0.38+/-0.09. Successful mitral valvuloplasty or replacement was documented by long-term normalization of end-diastolic dimensions. Early postoperative shortening fraction was significantly reduced (0.28+/-0.1, P<.01), but it improved to 0.40+/-0.07 (P<.01) on late follow-up, at which time only 1 patient had ventricular dysfunction. Preoperative shortening fractions did not correlate well with early or late postoperative values (r=.18 and r=.31, respectively). Seven of 32 surviving patients had preoperative shortening fractions <0.33 (mean, 0.26+/-0.05) and 25 >0.33 (mean, 0.39+/-0.08). Analysis of these subgroups showed no significant differences between the groups in early or late postoperative function. Duration of mitral insufficiency appeared to be associated with the development of atrial arrhythmias.
CONCLUSIONS: Late left ventricular function normalizes in children after surgical correction of mitral insufficiency. In contrast to adults, delay of surgery in children with significant mitral regurgitation until the onset of severe symptoms does not increase the risk for long-term ventricular dysfunction, although late atrial arrhythmias are more likely to be encountered.

Entities:  

Mesh:

Year:  1997        PMID: 9416894     DOI: 10.1161/01.cir.96.12.4280

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  6 in total

1.  Preoperative left ventricular end systolic dimension as a predictor of postoperative ventricular dysfunction in children with mitral regurgitation.

Authors:  J Y Lee; C I Noh; E J Bae; Y S Yun; J R Lee; Y J Kim
Journal:  Heart       Date:  2003-10       Impact factor: 5.994

2.  Outcome for Conservative Surgery for the Correction of Severe Mitral Valve Regurgitation in Children: A Single-Center Experience.

Authors:  Gianluca Brancaccio; Marcello Chinali; Matteo Trezzi; Carolina D'Anna; Claudia Esposito; Gabriele Rinelli; Walter Vignaroli; Sonia B Albanese; Fiore S Iorio; Adriano Carotti
Journal:  Pediatr Cardiol       Date:  2019-09-03       Impact factor: 1.655

Review 3.  Evaluation of Acquired Valvular Heart Disease by the Pediatrician: When to Follow, When to Refer for Intervention? Part I.

Authors:  Anita Saxena
Journal:  Indian J Pediatr       Date:  2015-07-05       Impact factor: 1.967

4.  Mitral Regurgitation and Serum N-Terminal Pro-Brain Natriuretic Peptide Levels in Children: A Modification of Adult Criteria.

Authors:  Elif Erolu; Figen Akalin
Journal:  Tex Heart Inst J       Date:  2022-07-01

5.  Indications for intervention in asymptomatic children with chronic mitral regurgitation.

Authors:  Joyce T Johnson; Aaron W Eckhauser; Nelangi M Pinto; Hsin-Yi Weng; L LuAnn Minich; Lloyd Y Tani
Journal:  Pediatr Cardiol       Date:  2014-10-11       Impact factor: 1.655

6.  The efficacy of mitral valve surgery in children with dilated cardiomyopathy and severe mitral regurgitation.

Authors:  John P Breinholt; Charles D Fraser; William J Dreyer; Anthony C Chang; E O'Brian Smith; Jeffrey S Heinle; E Dean McKenzie; Sarah K Clunie; Jeffrey A Towbin; Susan W Denfield
Journal:  Pediatr Cardiol       Date:  2007-09-11       Impact factor: 1.655

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.